FI951276A0 - Antibody conjugates with enhanced properties - Google Patents

Antibody conjugates with enhanced properties

Info

Publication number
FI951276A0
FI951276A0 FI951276A FI951276A FI951276A0 FI 951276 A0 FI951276 A0 FI 951276A0 FI 951276 A FI951276 A FI 951276A FI 951276 A FI951276 A FI 951276A FI 951276 A0 FI951276 A0 FI 951276A0
Authority
FI
Finland
Prior art keywords
antibody conjugates
enhanced properties
enhanced
properties
conjugates
Prior art date
Application number
FI951276A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI951276A (en
Inventor
Brendal Murray
Terence O'reilly
Gerd Pluschke
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI951276A0 publication Critical patent/FI951276A0/en
Publication of FI951276A publication Critical patent/FI951276A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
FI951276A 1994-03-21 1995-03-17 Antibody conjugates with improved properties FI951276A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94810173 1994-03-21

Publications (2)

Publication Number Publication Date
FI951276A0 true FI951276A0 (en) 1995-03-17
FI951276A FI951276A (en) 1995-09-22

Family

ID=8218230

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951276A FI951276A (en) 1994-03-21 1995-03-17 Antibody conjugates with improved properties

Country Status (11)

Country Link
JP (1) JPH0820545A (en)
KR (1) KR950031111A (en)
AU (1) AU1481795A (en)
CA (1) CA2144936A1 (en)
FI (1) FI951276A (en)
HU (1) HUT71776A (en)
IL (1) IL113022A (en)
NO (1) NO951061L (en)
NZ (1) NZ270734A (en)
RU (1) RU95104325A (en)
ZA (1) ZA952269B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2865737B1 (en) * 2004-02-03 2006-03-31 Anteis Sa BIOCOMPATIBLE RETICLE GEL

Also Published As

Publication number Publication date
FI951276A (en) 1995-09-22
NO951061L (en) 1995-09-22
NZ270734A (en) 1997-05-26
AU1481795A (en) 1995-09-28
NO951061D0 (en) 1995-03-20
IL113022A0 (en) 1995-06-29
IL113022A (en) 2000-02-29
JPH0820545A (en) 1996-01-23
HU9500586D0 (en) 1995-04-28
RU95104325A (en) 1996-12-27
CA2144936A1 (en) 1995-09-22
KR950031111A (en) 1995-12-18
ZA952269B (en) 1995-09-21
HUT71776A (en) 1996-01-29

Similar Documents

Publication Publication Date Title
ATE394489T1 (en) STREPTOCOCCUS ANTIGENS
DE69720320D1 (en) Interferon conjugates
DE69935516D1 (en) ANTIBODIES WITH IMPROVED PRODUCTABILITY
ID16966A (en) PRESSURE ANTIBODY PROPERTIES
DK145493D0 (en) ANTIBODY
DE69435044D1 (en) Rapamycin conjugates and antibodies
DK1075281T3 (en) Polyol-IFN- beta conjugates
DE69515514D1 (en) ABSORBENT ITEM WITH IMPROVED PROPERTIES
DE69524185D1 (en) TWO ROLLS-casting
DE69529288T2 (en) WATER-SOLUBLE POLYEN CONJUGATES
NO972868D0 (en) Oligonucleotide-dendrimer conjugates
SE9601050L (en) Packaging with sliding device
DE59507277D1 (en) Folder
ID28905A (en) ANTIBODIES WITH HIGH AFINITY
FI951276A0 (en) Antibody conjugates with enhanced properties
KR950029468U (en) Smuggling
SE9002479D0 (en) ANTIBODY CONJUGATES
DE9418346U1 (en) Stop damper
DE69123256D1 (en) ANTIQUE-ANTIBODY CONJUGATES
KR970043713U (en) Integrated damper with two frequencies
DE9406082U1 (en) folder
DE29521724U1 (en) folder
DE9419516U1 (en) Gate fitting
SE8902432D0 (en) ANTIBODY CONJUGATES
FI940841A0 (en) Lockoeppnare Foer can with undertryck

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG